Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.

Similar Items

• Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.
  od: Spriggs, M K, i dr.
  Izdano: (1987)
• Replacement of the Ectodomains of the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Recombinant Parainfluenza Virus Type 3 (PIV3) with Their Counterparts from PIV2 Yields Attenuated PIV2 Vaccine Candidates
  od: Tao, Tao, i dr.
  Izdano: (2000)
• A Recombinant Human Parainfluenza Virus Type 3 (PIV3) in Which the Nucleocapsid N Protein Has Been Replaced by That of Bovine PIV3 Is Attenuated in Primates
  od: Bailly, Jane E., i dr.
  Izdano: (2000)
• The Isolation of Parainfluenza 3 Virus from Fatal Cases of Pneumonia in Erythrocebus patas Monkeys
  od: Churchill, A. E.
  Izdano: (1963)
• Recovery of a Fully Viable Chimeric Human Parainfluenza Virus (PIV) Type 3 in Which the Hemagglutinin-Neuraminidase and Fusion Glycoproteins Have Been Replaced by Those of PIV Type 1
  od: Tao, Tao, i dr.
  Izdano: (1998)